The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.20
Bid: 49.90
Ask: 50.20
Change: 1.60 (3.29%)
Spread: 0.30 (0.601%)
Open: 48.45
High: 51.10
Low: 47.20
Prev. Close: 48.60
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3 Dec 2020 09:58

IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA

IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA

Read more
3 Dec 2020 09:08

IP Group's Artios signs research deal with Merck

(Sharecast News) - IP Group said its Artios portfolio company had signed a research deal with Merck of Germany that could more than double the value of the investment company's stake.

Read more
13 Oct 2020 10:37

UK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale

UK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale

Read more
13 Oct 2020 09:58

IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress

IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress

Read more
13 Oct 2020 08:30

IP Group portfolio firm Oxford Nanopore raises another £84.4m

(Sharecast News) - Intellectual property-based business investor IP Group announced on Tuesday that its portfolio company Oxford Nanopore Technologies has raised an additional £84.4m of new capital from existing and new investors, including International Holdings Company (IHC) and RPMI Railpen.

Read more
9 Oct 2020 10:37

IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test

IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test

Read more
7 Oct 2020 10:57

IP Group portfolio business offloads cystic fibrosis treatment programme to Roche

(Sharecast News) - Intellectual property company IP Group said on Wednesday that portfolio group Enterprise Therapeutics' TMEM16A cystic fibrosis treatment programme had been acquired by Swiss pharmaceutical giant Roche.

Read more
7 Oct 2020 08:55

TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy

TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy

Read more
7 Oct 2020 07:54

LONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers

LONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers

Read more
7 Oct 2020 07:40

LONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises

LONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises

Read more
10 Aug 2020 09:43

UK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform

UK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform

Read more
6 Aug 2020 09:38

UK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup

UK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup

Read more
5 Aug 2020 11:04

IP Group Net Asset Value Declines Amid Record Cash Realisations

IP Group Net Asset Value Declines Amid Record Cash Realisations

Read more
5 Aug 2020 08:33

IP Group in 'even stronger' financial position after first half

(Sharecast News) - IP Group reported net portfolio gains of £34.9m, or 3%, in its first half on Wednesday, with cash realisations rising to £113.7m from £7.1m a year earlier, exceeding investment by £76.9m.

Read more
3 Aug 2020 17:02

LONDON MARKET CLOSE: Manufacturing PMIs Spark Strong Start To August

LONDON MARKET CLOSE: Manufacturing PMIs Spark Strong Start To August

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.